Literature DB >> 16485841

Crisis occurrence and resolution in patients with severe and persistent mental illness: the contribution of suicidality.

Paul S Links1, Rahel Eynan, Jeffrey S Ball, Aiala Barr, Sean Rourke.   

Abstract

Assertive community treatment appears to have limited impact on the risk of suicide in persons with severe and persistent mental illness (SPMI). This exploratory prospective study attempts to understand this observation by studying the contribution of suicidality to the occurrence of crisis events in patients with SPMI. Specifically, an observer-rated measure of the need for hospitalization, the Crisis Triage Rating Scale, was completed at baseline, crisis occurrence, and resolution to determine how much the level of suicidality contributed to the deemed level of crisis. Second, observer-ratings of suicidal ideation, the Modified Scale for Suicide Ideation, and psychopathology and suicidality, Brief Psychiatric Rating Scale, were measured at baseline, crisis occurrence, and resolution. A self-report measure of distress, the Symptom Distress Scale, was completed at baseline, crisis occurrence, and resolution. Finally, the patients' crisis experiences were recorded qualitatively to compare with quantitative measures of suicidality. Almost 40% of the subjects experienced crisis events and more than a quarter of these events were judged to be severe enough to warrant the need for hospitalization. Our findings suggest that elevation of psychiatric symptoms is a major contributor to the crisis occurrences of individuals with SPMI; although the risk of suicide may have to be conceived as somewhat separate from crisis occurrence.

Entities:  

Mesh:

Year:  2005        PMID: 16485841     DOI: 10.1027/0227-5910.26.4.160

Source DB:  PubMed          Journal:  Crisis        ISSN: 0227-5910


  1 in total

1.  Validity and reliability of a novel Color-Risk Psychiatric Triage in a psychiatric emergency department.

Authors:  Alejandro Molina-López; Jeremy Bernardo Cruz-Islas; Mauricio Palma-Cortés; Diana Patricia Guizar-Sánchez; César Yehú Garfias-Rau; Martha Patricia Ontiveros-Uribe; Ana Fresán-Orellana
Journal:  BMC Psychiatry       Date:  2016-02-10       Impact factor: 3.630

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.